CROHNS DISEASE

This early-stage study tested a new biologic drug called AZD7798 in 112 people, including healthy volunteers and patients with Crohn's disease. The main goal was to check if the drug is safe and how the body processes it. Researchers gave single or repeated doses and monitored fo…

This study tested the safety of guselkumab in 38 people with moderately to severely active Crohn's disease. Participants received the drug first through an IV and then as injections. The main goal was to track side effects, including infections and injection reactions. This is a …

This study observed 92 adults with inflammatory bowel disease (Crohn's or ulcerative colitis) who were already receiving or starting vedolizumab. Researchers watched how patients and doctors chose between intravenous infusion or subcutaneous injection in everyday practice. The go…

This study followed 646 people with complex fistulas caused by Crohn's disease or other conditions. Researchers watched how standard surgeries performed in real clinics, without changing any treatments. The goal was to learn how often fistulas heal and what complications occur af…